Dimethyltryptamine

Psychedelic drug trip improves symptoms of depression for six months, breakthrough study finds

Author: Editorial 6th April 2023 0 Comments

Nina Massey reports for The Independent: “A psychedelic drug that gives trips lasting half an hour improves the symptoms of moderate to severe depression for up to six months, early trial results suggest. Biotechnology company Small Pharma announced the results of…
Read more

collaborative practice

depression, Dimethyltryptamine, Nina Massey, Psychedelic-assisted therapy, Robin Carhart-Harris, Small Pharma, The Independent

Looking for fresh articles?

Psychedelic drug trip improves symptoms of depression for six months, breakthrough study finds